Supervised machine learning including environmental factors to predict in-hospital outcomes in acute heart failure patients Article Swipe
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1093/ehjdh/ztae094
· OA: W4405412201
Aims While few traditional scores are available for risk stratification of patients hospitalized for acute heart failure (AHF), the potential benefit of machine learning (ML) is not well established. We aimed to assess the feasibility and accuracy of a supervised ML model including environmental factors to predict in-hospital major adverse events (MAEs) in patients hospitalized for AHF. Methods and results In April 2021, a French national prospective multicentre study included all consecutive patients hospitalized in intensive cardiac care unit. Patients admitted for AHF were included in the analyses. A ML model involving automated feature selection by least absolute shrinkage and selection operator (LASSO) and model building with a random forest (RF) algorithm was developed. The primary composite outcome was in-hospital MAE defined by death, resuscitated cardiac arrest, or cardiogenic shock requiring assistance. Among 459 patients included (age 68 ± 14 years, 68% male), 47 experienced in-hospital MAE (10.2%). Seven variables were selected by LASSO for predicting MAE in the training data set (n = 322): mean arterial pressure, ischaemic aetiology, sub-aortic velocity time integral, E/e′, tricuspid annular plane systolic excursion, recreational drug use, and exhaled carbon monoxide level. The RF model showed the best performance compared with other evaluated models [area under the receiver operating curve (AUROC) = 0.82, 95% confidence interval (CI) (0.78–0.86); precision-recall area under the curve = 0.48, 95% CI (0.42–0.5), F1 score = 0.56). Our ML model exhibited a higher AUROC compared with an existing score for the prediction of MAE (AUROC for our ML model: 0.82 vs. ACUTE HF score: 0.57; P < 0.001). Conclusion Our ML model including in particular environmental variables exhibited a better performance than traditional statistical methods to predict in-hospital outcomes in patients admitted for AHF. Study registration ClinicalTrials.gov identifier: NCT05063097.
